This inventor holds 1 USPTO granted patent. Top assignee: Ao Technology Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Martin Stoddart: Innovator in Chondrogenic Potential
Introduction
Martin Stoddart is a notable inventor based in Davos Dorf, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of mesenchymal stromal cells. His innovative work has the potential to influence medical treatments and regenerative medicine.
Latest Patents
Martin Stoddart holds a patent titled "Method of Determining or Influencing the Chondrogenic Potential of Mesenchymal Stromal Cells." This patent represents his research and findings in understanding how to enhance the chondrogenic potential of these cells, which is crucial for cartilage repair and regeneration.
Career Highlights
Stoddart is associated with Ao Technology AG, where he applies his expertise in biotechnology. His work at the company focuses on advancing technologies that can lead to breakthroughs in medical applications. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Martin Stoddart's contributions to the field of biotechnology, particularly through his patent, highlight his role as an innovator. His work continues to pave the way for advancements in regenerative medicine and cell therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile